Tower Research Capital (TRC)’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-6,680
| Closed | -$133K | – | 6914 |
|
2022
Q3 | $133K | Buy |
6,680
+5,169
| +342% | +$103K | ﹤0.01% | 2298 |
|
2022
Q2 | $10K | Sell |
1,511
-1,588
| -51% | -$10.5K | ﹤0.01% | 4525 |
|
2022
Q1 | $29K | Buy |
3,099
+1,684
| +119% | +$15.8K | ﹤0.01% | 3210 |
|
2021
Q4 | $20K | Sell |
1,415
-2,121
| -60% | -$30K | ﹤0.01% | 3701 |
|
2021
Q3 | $82K | Buy |
3,536
+1,173
| +50% | +$27.2K | ﹤0.01% | 2574 |
|
2021
Q2 | $59K | Sell |
2,363
-1,876
| -44% | -$46.8K | ﹤0.01% | 2896 |
|
2021
Q1 | $118K | Buy |
4,239
+3,671
| +646% | +$102K | ﹤0.01% | 2477 |
|
2020
Q4 | $20K | Sell |
568
-2,237
| -80% | -$78.8K | ﹤0.01% | 3891 |
|
2020
Q3 | $140K | Buy |
2,805
+2,609
| +1,331% | +$130K | ﹤0.01% | 2880 |
|
2020
Q2 | $9K | Buy |
+196
| New | +$9K | ﹤0.01% | 4079 |
|